Imiquimod: an immune response modifier.

Suppr

超能文献

作者信息

Dahl M V

机构信息

Department of Dermatology, University of Minnesota Medical School, Minneapolis, MN, USA.

出版信息

J Am Acad Dermatol. 2000 Jul;43(1 Pt 2):S1-5. doi: 10.1067/mjd.2000.107809.

DOI:10.1067/mjd.2000.107809

PMID:10861100

Abstract

摘要

相似文献

Imiquimod: an immune response modifier.

J Am Acad Dermatol. 2000 Jul;43(1 Pt 2):S1-5. doi: 10.1067/mjd.2000.107809.

Treatment of anogenital warts.

Dermatol Clin. 1998 Oct;16(4):829-34, xv. doi: 10.1016/s0733-8635(05)70055-3.

A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod.

J Infect Dis. 1998 Aug;178(2):551-5. doi: 10.1086/517472.

The use of topical 5% imiquimod during pregnancy: a case series.

Reprod Toxicol. 2006 Jan;21(1):1-2. doi: 10.1016/j.reprotox.2005.06.001. Epub 2005 Jul 21.

Imiquimod for genital warts.

Med Lett Drugs Ther. 1997 Dec 19;39(1016):118-9.

Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts.

Skin Therapy Lett. 2009 Jun;14(5):1-3, 5.

Imiquimod in clinical practice.

J Am Acad Dermatol. 2000 Jul;43(1 Pt 2):S12-7. doi: 10.1067/mjd.2000.107806.

Imiquimod: a cytokine inducer.

J Am Acad Dermatol. 2002 Oct;47(4 Suppl):S205-8. doi: 10.1067/mjd.2002.126586.

Local and systemic adverse effects of imiquimod therapy for external anogenital warts in men: report of three cases.

Int J STD AIDS. 2012 Dec;23(12):909-10. doi: 10.1258/ijsa.2012.012076.

New treatments for genital warts less than ideal: abstract and commentary.

JAMA. 1998 Jun 24;279(24):2003-4. doi: 10.1001/jama.279.24.2003.

引用本文的文献

Therapeutic advances in the topical treatment of cutaneous leishmaniasis: A review.

PLoS Negl Trop Dis. 2021 Mar 3;15(3):e0009099. doi: 10.1371/journal.pntd.0009099. eCollection 2021 Mar.

Anti-HPV Nanoemulsified-Imiquimod: A New and Potent Formulation to Treat Cervical Cancer.

AAPS PharmSciTech. 2020 Jan 6;21(2):54. doi: 10.1208/s12249-019-1558-x.

The effect of imiquimod on taste bud calcium transients and transmitter secretion.

Br J Pharmacol. 2016 Nov;173(21):3121-3133. doi: 10.1111/bph.13567. Epub 2016 Sep 6.

The application of Levulan-based photodynamic therapy with imiquimod in the treatment of recurrent basal cell carcinoma.

Med Sci Monit. 2012 Feb;18(2):PI5-9. doi: 10.12659/msm.882449.

A study on the use of imiquimod for the treatment of genital molluscum contagiosum and genital warts in female patients.

Indian J Sex Transm Dis AIDS. 2009 Jul;30(2):84-8. doi: 10.4103/0253-7184.62763.

Analysis of cellular and behavioral responses to imiquimod reveals a unique itch pathway in transient receptor potential vanilloid 1 (TRPV1)-expressing neurons.

Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3371-6. doi: 10.1073/pnas.1019755108. Epub 2011 Feb 7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Imiquimod: an immune response modifier.

J Am Acad Dermatol. 2000 Jul;43(1 Pt 2):S1-5. doi: 10.1067/mjd.2000.107809.

Treatment of anogenital warts.

Dermatol Clin. 1998 Oct;16(4):829-34, xv. doi: 10.1016/s0733-8635(05)70055-3.

A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod.

J Infect Dis. 1998 Aug;178(2):551-5. doi: 10.1086/517472.

The use of topical 5% imiquimod during pregnancy: a case series.

Reprod Toxicol. 2006 Jan;21(1):1-2. doi: 10.1016/j.reprotox.2005.06.001. Epub 2005 Jul 21.

Imiquimod for genital warts.

Med Lett Drugs Ther. 1997 Dec 19;39(1016):118-9.

Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts.

Skin Therapy Lett. 2009 Jun;14(5):1-3, 5.

Imiquimod in clinical practice.

J Am Acad Dermatol. 2000 Jul;43(1 Pt 2):S12-7. doi: 10.1067/mjd.2000.107806.

Imiquimod: a cytokine inducer.

J Am Acad Dermatol. 2002 Oct;47(4 Suppl):S205-8. doi: 10.1067/mjd.2002.126586.

Local and systemic adverse effects of imiquimod therapy for external anogenital warts in men: report of three cases.

Int J STD AIDS. 2012 Dec;23(12):909-10. doi: 10.1258/ijsa.2012.012076.

New treatments for genital warts less than ideal: abstract and commentary.

JAMA. 1998 Jun 24;279(24):2003-4. doi: 10.1001/jama.279.24.2003.

引用本文的文献

Therapeutic advances in the topical treatment of cutaneous leishmaniasis: A review.

PLoS Negl Trop Dis. 2021 Mar 3;15(3):e0009099. doi: 10.1371/journal.pntd.0009099. eCollection 2021 Mar.

Anti-HPV Nanoemulsified-Imiquimod: A New and Potent Formulation to Treat Cervical Cancer.

AAPS PharmSciTech. 2020 Jan 6;21(2):54. doi: 10.1208/s12249-019-1558-x.

The effect of imiquimod on taste bud calcium transients and transmitter secretion.

Br J Pharmacol. 2016 Nov;173(21):3121-3133. doi: 10.1111/bph.13567. Epub 2016 Sep 6.

The application of Levulan-based photodynamic therapy with imiquimod in the treatment of recurrent basal cell carcinoma.

Med Sci Monit. 2012 Feb;18(2):PI5-9. doi: 10.12659/msm.882449.

A study on the use of imiquimod for the treatment of genital molluscum contagiosum and genital warts in female patients.

Indian J Sex Transm Dis AIDS. 2009 Jul;30(2):84-8. doi: 10.4103/0253-7184.62763.

Analysis of cellular and behavioral responses to imiquimod reveals a unique itch pathway in transient receptor potential vanilloid 1 (TRPV1)-expressing neurons.

Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3371-6. doi: 10.1073/pnas.1019755108. Epub 2011 Feb 7.